Stay updated on XEN801 Topical Gel Clinical Trial
Sign up to get notified when there's something new on the XEN801 Topical Gel Clinical Trial page.

Latest updates to the XEN801 Topical Gel Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice appears at the top of the page announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s revision identifier changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error screen.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study record now shows a 403 Forbidden page instead of the previous study details. This indicates access to the record is blocked, removing key information about the study.SummaryDifference16%

- Check59 days agoChange DetectedThe footer now shows Revision: v3.6.6, replacing v3.6.5, signaling a backend update without altering the displayed study details.SummaryDifference0.1%

- Check81 days agoChange DetectedA new page revision, v3.6.5, was added and the previous revision, v3.6.4, was removed, signaling an updated version of the page.SummaryDifference0.1%

Stay in the know with updates to XEN801 Topical Gel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN801 Topical Gel Clinical Trial page.